target,target_id,target_uniprot,target_species,ligand,ligand_id,ligand_species,ligand_pubchem_cid,smiles,inchi,inchikey,type,action,action_comment,endogenous,primary_target,concentration_range,affinity_parameter,affinity_high,affinity_median,affinity_low,original_affinity_units,original_affinity_low_nm,original_affinity_median_nm,original_affinity_high_nm,original_affinity_relation,assay_description,receptor_site,ligand_context,pubmed_id Kv7.5,564,Q9NR82,Human,flindokalner,2307,,214350,COc1ccc(cc1[C@]1(F)C(=O)Nc2c1ccc(c2)C(F)(F)F)Cl,"InChI=1S/C16H10ClF4NO2/c1-24-13-5-3-9(17)7-11(13)15(18)10-4-2-8(16(19,20)21)6-12(10)22-14(15)23/h2-7H,1H3,(H,22,23)/t15-/m0/s1",ULYONBAOIMCNEH-HNNXBMFYSA-N,Activator,None,,,,,pEC50,,5.6,,,,,,,,,,11890900, Kv7.5,564,Q9NR82,Human,tetraethylammonium,2343,,5413,CC[N+](CC)(CC)CC,"InChI=1S/C8H20N/c1-5-9(6-2,7-3)8-4/h5-8H2,1-4H3/q+1",CBXCPBUEXACCNR-UHFFFAOYSA-N,Channel blocker,None,,,,,pIC50,1.5,,1.1,,,,,,,,,10787416|10816588, Kv7.5,564,Q9NR82,Human,XE991,2596,,656732,O=C1c2ccccc2C(c2c1cccc2)(Cc1ccncc1)Cc1ccncc1,"InChI=1S/C26H20N2O/c29-25-21-5-1-3-7-23(21)26(17-19-9-13-27-14-10-19,18-20-11-15-28-16-12-20)24-8-4-2-6-22(24)25/h1-16H,17-18H2",KHJFBUUFMUBONL-UHFFFAOYSA-N,Inhibitor,None,,,,,pIC50,,4.2,,IC50,,65000.0,,=,,,,10816588, Kv7.5,564,Q9NR82,Human,zinc pyrithione,2597,,415267,[S-]c1cccc[n+]1[O-].[S-]c1cccc[n+]1[O-].[Zn+2],"InChI=1S/2C5H5NOS.Zn/c2*7-6-4-2-1-3-5(6)8;/h2*1-4,8H;/q;;+2/p-2",OTPSWLRZXRHDNX-UHFFFAOYSA-L,Activator,None,,,,,pEC50,,5.0,,,,,,,,,,17435769, Kv7.5,564,Q9NR82,Human,linopirdine,2599,,3932,O=C1N(c2ccccc2)c2c(C1(Cc1ccncc1)Cc1ccncc1)cccc2,"InChI=1S/C26H21N3O/c30-25-26(18-20-10-14-27-15-11-20,19-21-12-16-28-17-13-21)23-8-4-5-9-24(23)29(25)22-6-2-1-3-7-22/h1-17H,18-19H2",YEJCDKJIEMIWRQ-UHFFFAOYSA-N,Inhibitor,None,,,,,pKd,,4.8,,Kd,,16000.0,,=,,,,10787416, Kv7.5,564,Q9NR82,Human,(S)-N-[1-(3-morpholin-4-yl-phenyl)-ethyl]-3-phenyl-acrylamide,2600,,9949648,O=C(N[C@H](c1cccc(c1)N1CCOCC1)C)/C=C/c1ccccc1,"InChI=1S/C21H24N2O2/c1-17(22-21(24)11-10-18-6-3-2-4-7-18)19-8-5-9-20(16-19)23-12-14-25-15-13-23/h2-11,16-17H,12-15H2,1H3,(H,22,24)/b11-10+/t17-/m0/s1",QMIMHUDEVKGOTQ-DVQDXYAYSA-N,Activator,None,,,,,,,,,,,,,,,,,16904708, Kv7.5,564,Q9NR82,Human,retigabine,2601,,121892,CCOC(=O)Nc1ccc(cc1N)NCc1ccc(cc1)F,"InChI=1S/C16H18FN3O2/c1-2-22-16(21)20-15-8-7-13(9-14(15)18)19-10-11-3-5-12(17)6-4-11/h3-9,19H,2,10,18H2,1H3,(H,20,21)",PCOBBVZJEWWZFR-UHFFFAOYSA-N,Activator,None,,,yes,,pEC50,,5.0,,EC50,,10000.0,,=,,,,11890900, Kv7.5,564,Q9NR82,Human,gabapentin,5483,,3446,NCC1(CCCCC1)CC(=O)O,"InChI=1S/C9H17NO2/c10-7-9(6-8(11)12)4-2-1-3-5-9/h1-7,10H2,(H,11,12)",UGJMXCAKCUNAIE-UHFFFAOYSA-N,Activator,Activation,,,,,pEC50,,8.72,,EC50,,1.9,,=,,,,30021858, Kv7.5,564,Q9NR82,Human,retigabine derivative 10g,11479,,155567226,CCOC(=O)Nc1ccc(cc1NC(=O)OC(C)(C)C)N(Cc1ccc(cc1)F)CC#C,"InChI=1S/C24H28FN3O4/c1-6-14-28(16-17-8-10-18(25)11-9-17)19-12-13-20(26-22(29)31-7-2)21(15-19)27-23(30)32-24(3,4)5/h1,8-13,15H,7,14,16H2,2-5H3,(H,26,29)(H,27,30)",FWQHRZXEQNUCSY-UHFFFAOYSA-N,Activator,None,,,,,pEC50,,6.0,,,,,,=,,,,30655942,